Cerebrospinal Fluid P-Tau(181P): Biomarker for Improved Differential Dementia Diagnosis

The goal of this study is to investigate the value of tau phosphorylated at threonine 181 (P-tau(181P)) in the Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker panel for differential dementia diagnosis in autopsy confirmed AD and non-AD patients. The study population consisted of 140 aut...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Autores principales: Struyfs, Hanne, Niemantsverdriet, Ellis, Goossens, Joery, Fransen, Erik, Martin, Jean-Jacques, De Deyn, Peter P., Engelborghs, Sebastiaan
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4470274/
https://ncbi.nlm.nih.gov/pubmed/26136723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2015.00138
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares